VYTRUS BIOTECH EO -01 (V5P) — Net Asset Momentum
VYTRUS BIOTECH EO -01 (V5P) recorded a net asset momentum of 41.3% as of December 2025, with net assets of €10.31 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See VYTRUS BIOTECH EO -01 (V5P) net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
VYTRUS BIOTECH EO -01 Net Asset Momentum (2021–2025)
This chart tracks VYTRUS BIOTECH EO -01's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +41.3%, with net assets of €10.31 Million EUR as of December 2025. For live market cap and overall valuation, see VYTRUS BIOTECH EO -01 stock valuation.
Annual Net Asset History for VYTRUS BIOTECH EO -01 (2021–2025)
The table below shows the complete annual net asset history for VYTRUS BIOTECH EO -01 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check VYTRUS BIOTECH EO -01 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €10.31 Million | €14.66 Million | €4.35 Million | ▲ +41.3% |
| 2024 | €7.29 Million | €11.13 Million | €3.84 Million | ▲ +37.8% |
| 2023 | €5.29 Million | €9.31 Million | €4.02 Million | ▲ +11.3% |
| 2022 | €4.75 Million | €8.00 Million | €3.25 Million | ▲ +11.8% |
| 2021 | €4.25 Million | €7.18 Million | €2.93 Million | — |